(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PRKAA2 mRNA] CTD PMID:31150632 (+)-taxifolin decreases phosphorylation ISO RGD:730888 6480464 taxifolin results in decreased phosphorylation of PRKAA2 protein CTD PMID:23691032 (-)-Arctigenin increases phosphorylation ISO RGD:730888 6480464 arctigenin results in increased phosphorylation of PRKAA2 protein CTD PMID:23691032 (-)-matairesinol increases phosphorylation ISO RGD:730888 6480464 matairesinol results in increased phosphorylation of PRKAA2 protein CTD PMID:23691032 (R)-lipoic acid multiple interactions ISO RGD:730889 6480464 [Thioctic Acid co-treated with Silicon] results in increased expression of PRKAA2 mRNA CTD PMID:34252510 (R,R)-tramadol multiple interactions EXP 6480464 [Tiletamine co-treated with Xylazine co-treated with Tramadol] results in increased expression of PRKAA2 mRNA CTD PMID:31276069 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of PRKAA2 mRNA CTD PMID:22265867 1,1-dichloroethene decreases expression ISO RGD:730889 6480464 vinylidene chloride results in decreased expression of PRKAA2 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO RGD:730889 6480464 ethylene dichloride results in decreased expression of PRKAA2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:730889 6480464 1, 2-Dimethylhydrazine results in decreased expression of PRKAA2 mRNA CTD PMID:22206623 1,3,7,9-tetramethyluric acid multiple interactions EXP 6480464 1 more ... CTD PMID:35872049 17alpha-ethynylestradiol multiple interactions ISO RGD:730889 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRKAA2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PRKAA2 mRNA CTD PMID:29097150 17beta-estradiol multiple interactions ISO RGD:730889 6480464 Estradiol inhibits the reaction [Dihydrotestosterone results in decreased phosphorylation of PRKAA2 protein] CTD PMID:16990341 17beta-estradiol multiple interactions ISO RGD:730888 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of PRKAA2 mRNA CTD PMID:30165855 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of PRKAA2 mRNA CTD PMID:26496021 17beta-estradiol decreases expression ISO RGD:730889 6480464 Estradiol results in decreased expression of PRKAA2 mRNA CTD PMID:19484750 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PRKAA2 mRNA CTD PMID:20068009 17beta-hydroxy-5alpha-androstan-3-one decreases phosphorylation ISO RGD:730889 6480464 Dihydrotestosterone results in decreased phosphorylation of PRKAA2 protein CTD PMID:16990341 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:730889 6480464 Estradiol inhibits the reaction [Dihydrotestosterone results in decreased phosphorylation of PRKAA2 protein] CTD PMID:16990341 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:730889 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRKAA2 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PRKAA2 gene] CTD PMID:17942748 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:730889 6480464 Tetrachlorodibenzodioxin results in increased expression of PRKAA2 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:730889 6480464 Tetrachlorodibenzodioxin affects the expression of PRKAA2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRKAA2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PRKAA2 mRNA CTD PMID:22298810 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:29474705 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of PRKAA2 mRNA CTD PMID:30723492 4-hydroxy-3-[4-(2-hydroxyphenyl)phenyl]-6-oxo-7H-thieno[2,3-b]pyridine-5-carbonitrile multiple interactions ISO RGD:730889 6480464 [[PRKAA1 gene co-treated with PRKAA2 gene] affects the susceptibility to 4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2 more ... CTD PMID:31974165 4-hydroxy-TEMPO multiple interactions ISO RGD:730888 6480464 tempol inhibits the reaction [PRKAA2 protein affects the expression of HSPA5 protein] CTD PMID:21145922 4-nonylphenol multiple interactions EXP 6480464 [4-nonylphenol results in increased susceptibility to bisphenol A] which results in decreased expression of PRKAA2 mRNA, [bisphenol A co-treated with 4-nonylphenol] results in decreased expression of PRKAA2 mRNA CTD PMID:30228064 acadesine multiple interactions ISO RGD:730888 6480464 acadesine promotes the reaction [Capsaicin results in increased expression of PRKAA2 protein] CTD PMID:36044967 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of PRKAA2 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of PRKAA2 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:730889 6480464 Aflatoxin B1 results in increased expression of PRKAA2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:730888 6480464 Aflatoxin B1 results in decreased methylation of PRKAA2 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:730888 6480464 Aflatoxin B1 results in increased expression of PRKAA2 mRNA CTD PMID:22100608 aflatoxin M1 decreases expression ISO RGD:730888 6480464 Aflatoxin M1 results in decreased expression of PRKAA2 mRNA CTD PMID:30928695 AICA ribonucleotide multiple interactions ISO RGD:730889 6480464 PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]] more ... CTD PMID:15806154 , PMID:21454484 AICA ribonucleotide multiple interactions EXP 6480464 PRKAA2 protein promotes the reaction [AICA ribonucleotide promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA]] CTD PMID:22815988 AICA ribonucleotide increases phosphorylation ISO RGD:730888 6480464 AICA ribonucleotide results in increased phosphorylation of PRKAA2 protein CTD PMID:18482975 AICA ribonucleotide multiple interactions ISO RGD:730888 6480464 AICA ribonucleotide results in increased phosphorylation of and results in increased activity of PRKAA2 protein, PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CYP4F2 mRNA] CTD PMID:16873680 , PMID:21205922 aldehydo-D-glucose multiple interactions ISO RGD:730888 6480464 [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides more ... CTD PMID:18482975 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of PRKAA2 mRNA, Glucose results in decreased expression of PRKAA2 protein CTD PMID:24349266 aldehydo-D-glucose affects response to substance EXP 6480464 PRKAA2 protein mutant form affects the susceptibility to Glucose deficiency CTD PMID:15806154 aldehydo-D-glucose multiple interactions ISO RGD:730889 6480464 [[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]] which results in decreased abundance of Adenosine Triphosphate more ... CTD PMID:15806154 more ... amiodarone increases phosphorylation ISO RGD:730888 6480464 Amiodarone results in increased phosphorylation of PRKAA2 protein CTD PMID:23912912 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PRKAA2 mRNA CTD PMID:16483693 amosite asbestos decreases methylation ISO RGD:730888 6480464 Asbestos, Amosite results in decreased methylation of PRKAA2 promoter CTD PMID:29626692 Arctiin increases phosphorylation ISO RGD:730888 6480464 arctiin results in increased phosphorylation of PRKAA2 protein CTD PMID:23691032 aristolochic acid A decreases expression ISO RGD:730888 6480464 aristolochic acid I results in decreased expression of PRKAA2 mRNA CTD PMID:33212167 ATP multiple interactions ISO RGD:730889 6480464 [[PRKAA1 gene co-treated with PRKAA2 gene] affects the susceptibility to Metformin] which results in decreased abundance of Adenosine Triphosphate more ... CTD PMID:31974165 atrazine multiple interactions ISO RGD:730889 6480464 Lycopene inhibits the reaction [Atrazine results in increased expression of PRKAA2 mRNA], Lycopene inhibits the reaction [Atrazine results in increased phosphorylation of PRKAA2 protein] CTD PMID:30360616 atrazine increases expression ISO RGD:730889 6480464 Atrazine results in increased expression of PRKAA2 mRNA CTD PMID:30360616 atrazine increases phosphorylation ISO RGD:730889 6480464 Atrazine results in increased phosphorylation of PRKAA2 protein CTD PMID:30360616 benzalkonium chloride increases expression ISO RGD:730889 6480464 Benzalkonium Compounds results in increased expression of PRKAA2 mRNA CTD PMID:31199489 benzo[a]pyrene decreases expression ISO RGD:730889 6480464 Benzo(a)pyrene results in decreased expression of PRKAA2 mRNA CTD PMID:22228805 benzo[a]pyrene decreases methylation ISO RGD:730888 6480464 Benzo(a)pyrene results in decreased methylation of PRKAA2 3' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:730888 6480464 7 more ... CTD PMID:20018196 bisphenol A multiple interactions EXP 6480464 [4-nonylphenol results in increased susceptibility to bisphenol A] which results in decreased expression of PRKAA2 mRNA more ... CTD PMID:26496021 , PMID:30228064 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PRKAA2 mRNA CTD PMID:27539358 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PRKAA2 gene CTD PMID:28505145 bisphenol A increases methylation ISO RGD:730889 6480464 bisphenol A results in increased methylation of PRKAA2 promoter CTD PMID:27312807 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PRKAA2 mRNA CTD PMID:25181051 more ... butanal decreases expression ISO RGD:730888 6480464 butyraldehyde results in decreased expression of PRKAA2 mRNA CTD PMID:26079696 cadmium sulfate multiple interactions ISO RGD:730889 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of PRKAA2 mRNA] CTD PMID:16221973 caffeine increases expression EXP 6480464 Caffeine results in increased expression of PRKAA2 mRNA CTD PMID:22583948 caffeine increases phosphorylation ISO RGD:730888 6480464 Caffeine results in increased phosphorylation of PRKAA2 protein CTD PMID:35688186 capsaicin increases phosphorylation ISO RGD:730888 6480464 Capsaicin results in increased phosphorylation of PRKAA2 protein CTD PMID:36044967 capsaicin multiple interactions ISO RGD:730888 6480464 acadesine promotes the reaction [Capsaicin results in increased expression of PRKAA2 protein], dorsomorphin inhibits the reaction [Capsaicin results in increased expression of PRKAA2 protein] CTD PMID:36044967 carbon nanotube decreases expression ISO RGD:730889 6480464 Nanotubes more ... CTD PMID:25554681 carmustine affects response to substance ISO RGD:730888 6480464 PRKAA2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 cisplatin multiple interactions ISO RGD:730888 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PRKAA2 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:730888 6480464 Cisplatin results in decreased expression of PRKAA2 mRNA CTD PMID:27392435 copper atom decreases expression EXP 6480464 Copper results in decreased expression of PRKAA2 mRNA CTD PMID:22465980 copper atom multiple interactions ISO RGD:730888 6480464 [Chelating Agents binds to Copper] which results in increased expression of PRKAA2 mRNA CTD PMID:30911355 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of PRKAA2 mRNA CTD PMID:22465980 copper(0) multiple interactions ISO RGD:730888 6480464 [Chelating Agents binds to Copper] which results in increased expression of PRKAA2 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO RGD:730888 6480464 Copper Sulfate results in increased expression of PRKAA2 mRNA CTD PMID:19549813 corosolic acid multiple interactions EXP 6480464 PRKAA2 protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]] more ... CTD PMID:34296331 corosolic acid decreases response to substance ISO RGD:730889 6480464 PRKAA2 gene mutant form results in decreased susceptibility to corosolic acid CTD PMID:34296331 crocidolite asbestos decreases methylation ISO RGD:730888 6480464 Asbestos, Crocidolite results in decreased methylation of PRKAA2 promoter CTD PMID:29626692 cyclosporin A decreases expression ISO RGD:730888 6480464 Cyclosporine results in decreased expression of PRKAA2 mRNA CTD PMID:27989131 cyproconazole increases expression ISO RGD:730889 6480464 cyproconazole results in increased expression of PRKAA2 mRNA CTD PMID:22045034 D-glucopyranose 6-phosphate multiple interactions ISO RGD:730889 6480464 [[PRKAA1 gene co-treated with PRKAA2 gene] affects the susceptibility to 4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2 more ... CTD PMID:31974165 D-glucose multiple interactions ISO RGD:730889 6480464 [[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]] which results in decreased abundance of Adenosine Triphosphate more ... CTD PMID:15806154 more ... D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of PRKAA2 mRNA, Glucose results in decreased expression of PRKAA2 protein CTD PMID:24349266 D-glucose multiple interactions ISO RGD:730888 6480464 [resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides more ... CTD PMID:18482975 D-glucose affects response to substance EXP 6480464 PRKAA2 protein mutant form affects the susceptibility to Glucose deficiency CTD PMID:15806154 DDT decreases expression EXP 6480464 DDT results in decreased expression of PRKAA2 mRNA CTD PMID:30207508 Deoxyschizandrin decreases phosphorylation ISO RGD:730888 6480464 schizandrin A results in decreased phosphorylation of PRKAA2 protein CTD PMID:23691032 dibutyl phthalate increases expression ISO RGD:730889 6480464 Dibutyl Phthalate results in increased expression of PRKAA2 mRNA CTD PMID:21266533 dihydroxyacetone multiple interactions ISO RGD:730889 6480464 [[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Dihydroxyacetone co-treated with S 4048]] which results in decreased abundance of Adenosine Triphosphate, [PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Dihydroxyacetone co-treated with S 4048] CTD PMID:31974165 dioxygen increases expression ISO RGD:730888 6480464 Oxygen deficiency results in increased expression of PRKAA2 mRNA CTD PMID:24236059 dioxygen multiple interactions EXP 6480464 PRKAA2 mutant form inhibits the reaction [[Nitrites co-treated with Oxygen deficiency] results in increased expression of PPARGC1A mRNA] CTD PMID:22892143 dioxygen increases expression EXP 6480464 Oxygen results in increased expression of PRKAA2 mRNA CTD PMID:22911455 dorsomorphin multiple interactions ISO RGD:730888 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:19625624 more ... doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of PRKAA2 mRNA CTD PMID:26721193 doxorubicin multiple interactions EXP 6480464 PRKAA2 protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]] more ... CTD PMID:34296331 doxorubicin decreases expression ISO RGD:730888 6480464 Doxorubicin results in decreased expression of PRKAA2 mRNA CTD PMID:29803840 econazole multiple interactions ISO RGD:730889 6480464 [tebuconazole co-treated with Econazole] results in increased phosphorylation of PRKAA2 protein CTD PMID:30698772 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of PRKAA2 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:730888 6480464 entinostat results in increased expression of PRKAA2 mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:730889 6480464 epoxiconazole results in decreased expression of PRKAA2 mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:730889 6480464 [Ethanol co-treated with PRKAA2 protein] affects the expression of PRKAA1 protein more ... CTD PMID:23448468 ethanol multiple interactions EXP 6480464 1 more ... CTD PMID:35872049 fenthion increases expression ISO RGD:730889 6480464 Fenthion results in increased expression of PRKAA2 mRNA CTD PMID:34813904 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of PRKAA2 mRNA CTD PMID:24136188 folic acid decreases expression ISO RGD:730889 6480464 Folic Acid results in decreased expression of PRKAA2 mRNA CTD PMID:25629700 folpet increases expression ISO RGD:730889 6480464 folpet results in increased expression of PRKAA2 mRNA CTD PMID:31558096 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PRKAA2 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of PRKAA2 mRNA CTD PMID:24136188 glucose multiple interactions ISO RGD:730889 6480464 [[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]] which results in decreased abundance of Adenosine Triphosphate more ... CTD PMID:15806154 more ... glucose decreases expression EXP 6480464 Glucose results in decreased expression of PRKAA2 mRNA, Glucose results in decreased expression of PRKAA2 protein CTD PMID:24349266 glucose multiple interactions ISO RGD:730888 6480464 [resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides more ... CTD PMID:18482975 glucose affects response to substance EXP 6480464 PRKAA2 protein mutant form affects the susceptibility to Glucose deficiency CTD PMID:15806154 glyphosate decreases expression ISO RGD:730888 6480464 glyphosate results in decreased expression of PRKAA2 mRNA CTD PMID:31295307 gramine increases phosphorylation ISO RGD:730888 6480464 gramine results in increased phosphorylation of PRKAA2 protein CTD PMID:23691032 hexaconazole increases expression ISO RGD:730889 6480464 hexaconazole results in increased expression of PRKAA2 mRNA CTD PMID:22045034 hexadecanoic acid multiple interactions ISO RGD:730888 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of PRKAA2 mRNA CTD PMID:30547786 histamine multiple interactions ISO RGD:730888 6480464 [PRKAA1 protein co-treated with PRKAA2 protein] affects the reaction [Histamine results in increased phosphorylation of NOS2 protein] CTD PMID:21145922 lipoic acid multiple interactions ISO RGD:730889 6480464 [Thioctic Acid co-treated with Silicon] results in increased expression of PRKAA2 mRNA CTD PMID:34252510 lipopolysaccharide decreases expression ISO RGD:730889 39456138 lipopolysaccharide decreases expression of Prkaa2 mRNA in left cardiac chamber RGD lycopene increases phosphorylation ISO RGD:730889 6480464 Lycopene results in increased phosphorylation of PRKAA2 protein CTD PMID:30360616 lycopene increases expression ISO RGD:730889 6480464 Lycopene results in increased expression of PRKAA2 mRNA CTD PMID:30360616 lycopene multiple interactions ISO RGD:730889 6480464 Lycopene inhibits the reaction [Atrazine results in increased expression of PRKAA2 mRNA], Lycopene inhibits the reaction [Atrazine results in increased phosphorylation of PRKAA2 protein] CTD PMID:30360616 mercury dichloride decreases expression ISO RGD:730889 6480464 Mercuric Chloride results in decreased expression of PRKAA2 mRNA CTD PMID:22019852 metformin multiple interactions ISO RGD:730888 6480464 Metformin results in increased phosphorylation of and results in increased activity of PRKAA2 protein CTD PMID:16873680 metformin multiple interactions ISO RGD:730889 39456138 metformin inhibits the reaction [lipopolysaccharide decreases expression of Prkaa2 mRNA in left cardiac chamber] and decreases expression of Prkaa2 mRNA in left cardiac chamber RGD metformin increases phosphorylation EXP 6480464 Metformin results in increased phosphorylation of PRKAA2 protein CTD PMID:19594306 metformin increases activity EXP 6480464 Metformin results in increased activity of PRKAA2 protein CTD PMID:18484962 metformin affects response to substance ISO RGD:730889 6480464 PRKAA2 protein affects the susceptibility to Metformin CTD PMID:20847317 metformin multiple interactions EXP 6480464 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Metformin results in increased phosphorylation of and results in increased activity of PRKAA2 protein], Metformin results in increased phosphorylation of and results in increased activity of PRKAA2 protein CTD PMID:21186350 metformin multiple interactions ISO RGD:730889 6480464 [[PRKAA1 gene co-treated with PRKAA2 gene] affects the susceptibility to Metformin] which results in decreased abundance of Adenosine Triphosphate more ... CTD PMID:19052259 more ... methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of PRKAA2 mRNA CTD PMID:30467583 methidathion increases expression ISO RGD:730889 6480464 methidathion results in increased expression of PRKAA2 mRNA CTD PMID:34813904 methotrexate multiple interactions ISO RGD:730888 6480464 PRKAA2 mutant form inhibits the reaction [Methotrexate results in increased expression of HMOX1 mRNA] more ... CTD PMID:25575725 N-acetyl-L-cysteine multiple interactions ISO RGD:730889 6480464 Acetylcysteine inhibits the reaction [[PRKAA2 protein affects the susceptibility to [Air Pollutants results in increased abundance of Particulate Matter]] which results in increased phosphorylation of RELA protein] more ... CTD PMID:29753072 nickel atom decreases expression ISO RGD:730888 6480464 Nickel results in decreased expression of PRKAA2 mRNA CTD PMID:24768652 , PMID:25583101 nicotinamide multiple interactions ISO RGD:730888 6480464 Niacinamide inhibits the reaction [6 more ... CTD PMID:18482975 nicotine increases expression EXP 6480464 Nicotine results in increased expression of PRKAA2 mRNA CTD PMID:22265867 nicotinic acid increases activity ISO RGD:730888 6480464 Niacin results in increased activity of PRKAA2 protein CTD PMID:14749208 nitrites multiple interactions EXP 6480464 PRKAA2 mutant form inhibits the reaction [[Nitrites co-treated with Oxygen deficiency] results in increased expression of PPARGC1A mRNA] CTD PMID:22892143 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of PRKAA2 mRNA CTD PMID:26720608 oleic acid multiple interactions ISO RGD:730888 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of PRKAA2 mRNA CTD PMID:30547786 paracetamol affects expression ISO RGD:730889 6480464 Acetaminophen affects the expression of PRKAA2 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PRKAA2 mRNA CTD PMID:33387578 paraquat affects response to substance ISO RGD:730889 6480464 PRKAA2 gene affects the susceptibility to Paraquat CTD PMID:25092649 paraquat increases expression ISO RGD:730889 6480464 Paraquat results in increased expression of PRKAA2 protein CTD PMID:27324791 paraquat increases phosphorylation ISO RGD:730889 6480464 Paraquat results in increased phosphorylation of PRKAA2 protein CTD PMID:25092649 phenobarbital decreases expression ISO RGD:730889 6480464 Phenobarbital results in decreased expression of PRKAA2 mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:730888 6480464 Phenylmercuric Acetate results in decreased expression of PRKAA2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:730888 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKAA2 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:730889 6480464 pirinixic acid results in increased expression of PRKAA2 mRNA CTD PMID:18301758 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of PRKAA2 mRNA CTD PMID:19236843 platycodin D multiple interactions ISO RGD:730889 6480464 platycodin D results in increased phosphorylation of and results in increased activity of PRKAA2 protein CTD PMID:30599906 potassium chromate increases expression ISO RGD:730888 6480464 potassium chromate(VI) results in increased expression of PRKAA2 mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:730889 6480464 Pregnenolone Carbonitrile results in decreased expression of PRKAA2 mRNA CTD PMID:28903501 progesterone increases expression EXP 6480464 Progesterone results in increased expression of PRKAA2 mRNA CTD PMID:20726854 reactive oxygen species affects abundance ISO RGD:730888 6480464 PRKAA2 protein affects the abundance of Reactive Oxygen Species CTD PMID:21145922 resveratrol multiple interactions ISO RGD:730888 6480464 [resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides more ... CTD PMID:16873680 more ... resveratrol affects response to substance ISO RGD:730889 6480464 PRKAA2 protein affects the susceptibility to resveratrol CTD PMID:23090186 resveratrol increases phosphorylation ISO RGD:730888 6480464 resveratrol results in increased phosphorylation of PRKAA2 protein CTD PMID:18482975 , PMID:20080969 resveratrol decreases expression ISO RGD:730889 6480464 resveratrol results in decreased expression of PRKAA2 mRNA CTD PMID:22610192 resveratrol decreases activity ISO RGD:730889 6480464 resveratrol results in decreased activity of PRKAA2 protein CTD PMID:19934007 resveratrol increases phosphorylation ISO RGD:730889 6480464 resveratrol results in increased phosphorylation of PRKAA2 protein CTD PMID:17438283 resveratrol multiple interactions ISO RGD:730889 6480464 PRKAA2 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]] more ... CTD PMID:17438283 more ... SB 431542 multiple interactions ISO RGD:730888 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos decreases methylation ISO RGD:730888 6480464 Asbestos, Serpentine results in decreased methylation of PRKAA2 promoter CTD PMID:29626692 silicon atom multiple interactions ISO RGD:730889 6480464 [Thioctic Acid co-treated with Silicon] results in increased expression of PRKAA2 mRNA CTD PMID:34252510 sodium arsenate increases expression ISO RGD:730889 6480464 sodium arsenate results in increased expression of PRKAA2 mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO RGD:730888 6480464 sodium arsenite results in decreased expression of PRKAA2 mRNA CTD PMID:34032870 succimer multiple interactions ISO RGD:730889 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRKAA2 mRNA CTD PMID:26378955 sucrose multiple interactions EXP 6480464 [Dietary Fats co-treated with Sucrose] results in decreased expression of PRKAA2 mRNA, Biological Products inhibits the reaction [[Dietary Fats co-treated with Sucrose] results in decreased expression of PRKAA2 mRNA] CTD PMID:31175915 sulindac multiple interactions EXP 6480464 [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PRKAA2 mRNA CTD PMID:20371263 syringin decreases phosphorylation ISO RGD:730888 6480464 syringin results in decreased phosphorylation of PRKAA2 protein CTD PMID:23691032 tebuconazole multiple interactions ISO RGD:730889 6480464 [tebuconazole co-treated with Econazole] results in increased phosphorylation of PRKAA2 protein CTD PMID:30698772 temozolomide affects response to substance ISO RGD:730888 6480464 PRKAA2 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 testosterone enanthate affects expression ISO RGD:730888 6480464 testosterone enanthate affects the expression of PRKAA2 mRNA CTD PMID:17440010 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of PRKAA2 mRNA CTD PMID:12734012 tetrachloromethane decreases expression ISO RGD:730889 6480464 Carbon Tetrachloride results in decreased expression of PRKAA2 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 1 more ... CTD PMID:31150632 , PMID:35872049 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PRKAA2 mRNA CTD PMID:16239168 , PMID:31150632 tetrachloromethane affects expression ISO RGD:730889 6480464 Carbon Tetrachloride affects the expression of PRKAA2 mRNA CTD PMID:17484886 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of PRKAA2 mRNA CTD PMID:34492290 tramadol multiple interactions EXP 6480464 [Tiletamine co-treated with Xylazine co-treated with Tramadol] results in increased expression of PRKAA2 mRNA CTD PMID:31276069 triadimefon decreases phosphorylation EXP 6480464 triadimefon results in decreased phosphorylation of PRKAA2 protein CTD PMID:36179991 trichostatin A increases expression ISO RGD:730888 6480464 trichostatin A results in increased expression of PRKAA2 mRNA CTD PMID:24935251 Triptolide increases expression EXP 6480464 triptolide results in increased expression of PRKAA2 mRNA CTD PMID:23639586 valproic acid increases expression ISO RGD:730889 6480464 Valproic Acid results in increased expression of PRKAA2 mRNA CTD PMID:22045034 valproic acid increases expression ISO RGD:730888 6480464 Valproic Acid results in increased expression of PRKAA2 mRNA CTD PMID:19101580 more ... valproic acid multiple interactions ISO RGD:730888 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKAA2 mRNA CTD PMID:27188386 valproic acid affects expression ISO RGD:730888 6480464 Valproic Acid affects the expression of PRKAA2 mRNA CTD PMID:25979313 vancomycin increases expression ISO RGD:730889 6480464 Vancomycin results in increased expression of PRKAA2 mRNA CTD PMID:18930951 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of PRKAA2 mRNA CTD PMID:23555832 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of PRKAA2 gene CTD PMID:31682807 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of PRKAA2 mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of PRKAA2 mRNA CTD PMID:23034163 xylazine multiple interactions EXP 6480464 [Tiletamine co-treated with Xylazine co-treated with Tramadol] results in increased expression of PRKAA2 mRNA CTD PMID:31276069 zearalenone increases expression ISO RGD:730889 6480464 Zearalenone results in increased expression of PRKAA2 mRNA CTD PMID:30717214
